BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20888287)

  • 1. The future of the β-lactams.
    Llarrull LI; Testero SA; Fisher JF; Mobashery S
    Curr Opin Microbiol; 2010 Oct; 13(5):551-7. PubMed ID: 20888287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Part II. Introduction to the beta-lactam antibiotics.
    Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of Mutations in the
    Ranjitkar S; Reck F; Ke X; Zhu Q; McEnroe G; Lopez SL; Dean CR
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31270174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Lactams and β-Lactamase Inhibitors: An Overview.
    Bush K; Bradford PA
    Cold Spring Harb Perspect Med; 2016 Aug; 6(8):. PubMed ID: 27329032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Part V. Other beta-lactam antimicrobials.
    Gibbs WJ; Cooper TW; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Jan; 100(1):23-5. PubMed ID: 17378498
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli.
    Pitout JD; Sanders CC; Sanders WE
    Am J Med; 1997 Jul; 103(1):51-9. PubMed ID: 9236486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacterial resistance against beta-lactam antibiotics].
    Andersen BM
    Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3233-9. PubMed ID: 2256036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM; Bonomo RA
    Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallo-beta-lactamases of Pseudomonas aeruginosa--a novel mechanism resistance to beta-lactam antibiotics.
    Sacha P; Wieczorek P; Hauschild T; Zórawski M; Olszańska D; Tryniszewska E
    Folia Histochem Cytobiol; 2008; 46(2):137-42. PubMed ID: 18519228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Antibiotics in the Treatment of Urinary Tract Infections.
    Naber KG; Wagenlehner FME
    Eur Urol Focus; 2019 Jan; 5(1):10-12. PubMed ID: 30555037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactamases and beta-lactamase inhibitors.
    Williams JD
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactam antibiotics: newer formulations and newer agents.
    Martin SI; Kaye KM
    Infect Dis Clin North Am; 2004 Sep; 18(3):603-19, ix. PubMed ID: 15308278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of beta-lactam antibiotics in response to the evolution of beta-lactamases.
    Essack SY
    Pharm Res; 2001 Oct; 18(10):1391-9. PubMed ID: 11697463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural beta-lactam antibiotics.
    Aoki H; Okuhara M
    Annu Rev Microbiol; 1980; 34():159-81. PubMed ID: 7002023
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-lactams in the new millennium. Part-I: monobactams and carbapenems.
    Singh GS
    Mini Rev Med Chem; 2004 Jan; 4(1):69-92. PubMed ID: 14754445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New molecules from old classes: revisiting the development of beta-lactams.
    Page MG; Heim J
    IDrugs; 2009 Sep; 12(9):561-5. PubMed ID: 19697275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    Hsueh PR; Chen WH; Luh KT
    Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia.
    Vargas-Alzate CA; Higuita-Gutiérrez LF; Jiménez-Quiceno JN
    Biomedica; 2019 May; 39(s1):35-49. PubMed ID: 31529847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.